See today's BioWorld
To read the full story, subscribe or sign in.

Genor raises $347M via HK IPO, aims to strengthen breast cancer franchise

Oct. 7, 2020
By Elise Mak
BEIJING – Biologics developer Genor Biopharma Co. Ltd. raised HK$2.69 billion (US$347 million) via a pre-revenue IPO on the Hong Kong Stock Exchange on Oct. 7, with shares (HKEX:6998) trading 16.25% higher to close at HK$27.95.
BioWorld Financings Cancer IPO China